Erratum on: A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates

Erratum on: A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates

Bibliographic Details
Main Author:	Frontiers eProduction Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-09-01
Series:	Frontiers in Immunology
Subjects:	Dengue Vaccine non-human primates neutralizing antibodies T cell responses needle-free delivery
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00436/full

Similar Items

A rapid immunization strategy with a live attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
by: Yuping eAmbuel, et al.
Published: (2014-06-01)

Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice
by: Ajit Kulkarni, et al.
Published: (2017-03-01)

Neutralizing Antibodies after Infection with Dengue 1 Virus
by: Gustavo Kourí, et al.
Published: (2007-02-01)

Proof of concept in non-human primates of the heterologous prime-boost strategy combining dengue-2 virus and recombinant proteins including domain III of the viral envelope protein
by: Iris Valdés, et al.

Pichia pastoris-expressed Dengue 3 Envelope-based Virus-like Particles Elicit Predominantly Domain III-Focused High Titer Neutralizing Antibodies
by: Lav eTripathi, et al.
Published: (2015-09-01)

The Human Antibody Response to Dengue Virus Infection
by: Aravinda M. de Silva, et al.
Published: (2011-11-01)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
by: David A. Spencer, et al.
Published: (2021-05-01)

Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity
by: Subenya Injampa, et al.
Published: (2017-11-01)

Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates
by: Tal Noy-Porat, et al.
Published: (2016-03-01)

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
by: Jue Hou, et al.
Published: (2019-06-01)

Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
by: Natasha D Durham, et al.
Published: (2019-12-01)

A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies
by: Jean Claude Balingit, et al.
Published: (2020-06-01)

Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands
by: Guy El Helou, et al.
Published: (2020-06-01)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
by: Jiansheng Lu, et al.
Published: (2018-06-01)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
by: Matthew H. Collins, et al.
Published: (2017-05-01)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
by: Vincent Dussupt, et al.
Published: (2021-02-01)

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
by: David R. Martinez, et al.
Published: (2020-10-01)

Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus
by: Daniel R. Ripoll, et al.
Published: (2019-06-01)

Utility, limitations and future of non-human primates for dengue research and vaccine development
by: Laura eWhite, et al.
Published: (2014-09-01)

Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells
by: Minh Huong Phu Ly, et al.
Published: (2018-01-01)

Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection
by: Angeline Rouers, et al.
Published: (2021-05-01)

A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
by: Guntur Fibriansah, et al.
Published: (2014-03-01)

Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
by: Chakraborty, A.K, et al.
Published: (2022)

A tetravalent dengue nanoparticle stimulates antibody production in mice
by: Silva Elisângela F, et al.
Published: (2012-03-01)

Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques
by: Nan Gao, et al.
Published: (2020-01-01)

Monoclonal antibody-based capture ELISA in the diagnosis of previous dengue infection
by: Chukiat Sirivichayakul, et al.
Published: (2019-10-01)

Elicitation of broadly neutralizing antibodies against HIV-1 – the germline/maturation hypothesis
by: Prabakaran ePonraj, et al.
Published: (2014-08-01)

Can nonhuman primates serve as models for investigating dengue disease pathogenesis?
by: Kristina eClark, et al.
Published: (2013-10-01)

Erratum on: Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
by: Frontiers eProduction Office
Published: (2014-11-01)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
by: Maria G. Guzman, et al.
Published: (2010-12-01)

Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)
by: Nor Azila Muhammad Azami, et al.
Published: (2018-03-01)

ANTIBODY ANTI-DENGUE PROFILE IN DENGUE HEMORRHAGIC FEVER PATIENTS AT DR. SOETOMO HOSPITAL, SURABAYA
by: Langgeng A Waskito, et al.
Published: (2016-11-01)

Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies
by: Olga V. Chervyakova, et al.
Published: (2016-06-01)

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies.
by: Heidi Edelgard Drummer, et al.
Published: (2014-07-01)

Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?
by: Roberto Burioni, et al.
Published: (2012-09-01)

Neutralizing Antibody Response and SARS Severity
by: Mei-Shang Ho, et al.
Published: (2005-11-01)

Clinical Efficacy, Safety, and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (CYD-TDV) in Children: A Systematic Review with Meta-analysis
by: Moffat Malisheni, et al.
Published: (2017-08-01)

Prevalencia de anticuerpos neutralizantes contra los serotipos del virus dengue en universitarios de Tabasco, México Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico
by: Gilma Guadalupe Sánchez-Burgos, et al.
Published: (2008-10-01)

Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
by: Jisang Park, et al.
Published: (2020-02-01)